G120K-PEG, a human GH antagonist, decreases GH signal transduction in the liver of mice

Molecular and Cellular Endocrinology

Volumn 192, Issue 1-2, 2002, Pages 65-74

  Thirone, Ana C P ^a   Carvalho, Carla R O ^a   Saad, Mario J A ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

G120K PEG; Growth hormone signaling (mice)

Indexed keywords

GROWTH HORMONE ANTAGONIST; HORMONE ANTAGONIST; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; PROTEIN SHC; UNCLASSIFIED DRUG; G120K PEG; G120K-PEG; GROWTH HORMONE RECEPTOR; HUMAN GROWTH HORMONE; INSULIN RECEPTOR SUBSTRATE 1 PROTEIN; INSULIN RECEPTOR SUBSTRATE 2 PROTEIN; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN; INSULIN RECEPTOR SUBSTRATE-2 PROTEIN; JAK2 PROTEIN, HUMAN; JAK2 PROTEIN, MOUSE; JANUS KINASE 2; MACROGOL DERIVATIVE; ONCOPROTEIN; PHOSPHOPROTEIN; PHOSPHOTYROSINE; PROLACTIN; PROTEIN; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SRC HOMOLOGY 2 DOMAIN CONTAINING, TRANSFORMING PROTEIN 1; SRC HOMOLOGY 2 DOMAIN-CONTAINING, TRANSFORMING PROTEIN 1; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIMERIZATION; GENE MUTATION; HUMAN; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; CHEMISTRY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHOSPHORYLATION; PROTEIN PROCESSING;

ANIMAL; DIMERIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HORMONE ANTAGONISTS; HUMAN; HUMAN GROWTH HORMONE; LIVER; MALE; MICE; PHOSPHOPROTEINS; PHOSPHORYLATION; PHOSPHOTYROSINE; POLYETHYLENE GLYCOLS; PROLACTIN; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-TYROSINE KINASE; PROTEINS; RECEPTORS, SOMATOTROPIN; SIGNAL TRANSDUCTION; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JANUS KINASE 2; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS;

EID: 0037188817     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00110-7     Document Type: Article

References (48)

1. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase
2. Mechanism of signaling by growth hormone receptor
3. Growth hormone, interferon-gama, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1
4. Growth hormone, interferon-gama, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling
5. Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants
6. A growth hormone antagonist protects mice against streptozotocin-induced glomerulosclerosis even in the presence of elevated levels of glucose and glycated hemoglobin
7. In vitro and in vivo studies of antagonistic effects of human growth hormone analogs
8. Amino acid residues in the third α-helix of growth hormone involved in growth promoting activity
9. Functional antagonism between endogenous mouse growth-hormone (GH) and a GH analog results in dwarf transgenic mice
10. Expression of a mutaded bovine growth hormone gene suppresses growth of transgenic mice
11. Glycine-119 of bovine growth-hormone is critical for growth-promoting activity
12. Dimerization of the extracellular domain of the human growth-hormone receptor by a single hormone molecule
13. High-resolution epitope mapping in hGH-receptor interactions by alanine-scaning mutagenesis
14. Rational design of receptor-specific variants of human growth hormone
15. G120R, a human growth hormone antagonist, shows Zinc-dependent agonist and antagonist activity on Nb2 cells
16. Effect of growth-hormone on carbohydrate and lipid metabolism
17. Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex
18. Inhibition of diabetic nephropathy by a GH antagonist: A molecular analysis
19. Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease
20. Inhibitory effect pf a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice
21. Mechanism-based design of prolactin receptor antagonists
22. Rational design of potent antagonists to the human growth-hormone receptor
23. The human growth hormone antagonist B2036 does not interact with the prolactin receptor
24. Sequence-function relationships within the expanding family of prolacin, growth hormone, placental lactogen and related proteins in mammals
25. Mode of action of pituitary growth hormone on target cells
26. The growth hormone/prolactin receptor family
27. Cytokine signal transduction
28. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
29. Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2
30. Contrasting acute in vivo nuclear actions of growth hormone and prolactin
31. Growth hormone receptor and serum binding protein: Purification, cloning and expression
32. Regulation of rat growth hormone receptor gene expression
33. A growth-hormone (GH) analog can antagonize the ability of native GH to promote differentiation of 3T3-F442a preadipocytes and stimulate insulin-like and lipolytic activities in primary rat adipocytes
34. Preparation and characterization of poly(ethylene glycol)ylated human growth hormone antagonist
35. Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate-1 and its association with phosphatidylinositol 3-kinase in primary adipocytes
36. Activation of receptor-associated tyrosine kinase JAK2 by prolactin
37. Stimulation of tyrosine phosphorylation in human cell by activation of the growth hormone receptor
38. Essential role of growth hormone in ischemia-induced retinal neovascularization
39. Growth hormone stimulates tyrosine phosphorylation of insulin receptor substrate-1
40. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of Insulin Receptor Substrates 1 and 2 and Shc in rat tissues
41. Tissue distribution, characterization, and regulation of messenger ribonucleic acid for growth hormone receptor and serum binding protein in the rat
42. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Procedure and some applications
43. Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant
44. Signal transduction by receptors with tyrosine kinase activity
45. Growth hormone promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2
46. Structural and functional basis for hormone binding and receptor oligomerization
47. Glomerulosclerosis in mice transgenic for native or mutaded bovine growth hormone gene
48. Use of functionalized polyethylene glycols for modification of polypeptides